ALZN
Alzamend Neuro Inc
NASDAQ: ALZN · HEALTHCARE · BIOTECHNOLOGY
$1.14
+7.55% today
Updated 2026-04-30
Market cap
$4.03M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.67
Dividend yield
—
52W range
$1 – $6
Volume
0.1M
Alzamend Neuro Inc (ALZN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-250.00%
ROA
-107.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | — | $-69456.00 | — | — | — |
| 2017 | — | $-1.57M | — | — | — |
| 2018 | — | $-932000.00 | — | — | — |
| 2019 | $0.00 | $-4.86M | — | — | — |
| 2020 | $0.00 | $-4.40M | — | — | — |
| 2021 | $0.00 | $-5.05M | — | — | — |
| 2022 | $0.00 | $-12.36M | — | — | — |
| 2023 | $0.00 | $-14.88M | — | — | — |
| 2024 | $0.00 | $-9.95M | — | — | — |
| 2025 | $0.00 | $-4.51M | — | — | — |